Epstein-barr Virus Infections
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections [Phase 3]
Phase 3 clinical trial evaluating multivirus-specific T-cell transfer after stem cell transplantation to treat or prevent AdV, CMV, and EBV …
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft [Phase 4]
A Phase 4 clinical trial is evaluating whether a single dose of rituximab (375 mg/m2) can prevent Epstein-Barr virus infection and post-tran…